- Home
- » Tags
- » Idalopirdine
Top View
- It's Role in Maintaining the Survival of Nerve Cells in Alzheimer's Disease
- Nanocarriers for Alzheimer's Disease
- Sanofi Could Pursue Other Oncology M&A Targets After Medivation Loss
- Dietary Restriction of Amino Acids for Cancer Therapy
- Antagonism of the 5-HT6 Receptor E Preclinical Rationale for the Treatment of Alzheimer's Disease
- Research Advocacy Training
- Bioactive Compound Library Plus (96-Well)
- The 5-HT6 Receptor Antagonist Idalopirdine Potentiates the Effects
- Treatment Combinations for Alzheimer's Disease
- Accepted Manuscript
- Novel N-Arylsulfonylindoles Targeted As Ligands of the 5-HT6 Receptor
- The 5-HT6 Receptor Antagonist Idalopirdine Potentiates The
- PUBLICATIONS CMA 12 Microdialysis Probes
- Advances in Developing Novel Therapeutic Strategies for Alzheimer’S Disease Jiqing Cao1,2,3, Jianwei Hou1,2, Jing Ping3 and Dongming Cai1,2,3*
- Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development
- IDALOPIRDINE PROGRAM – CPAD ANNUAL MEETING 2019 Mads Dalsgaard, SVP Exp Med & Clin Dev Objectives Brief Overview of the Idalopirdine Trials and Dataset
- Small Molecule Drugs for Treatment of Alzheimer's Diseases
- University of Birmingham Central 5-HT Receptors and Their
- AVN-101: a Multi-Target Drug Candidate for the Treatment of CNS Disorders
- Small Molecule Drugs for Treatment of Alzheimer's Diseases
- Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A
- Study Protocol
- Gene-Environment Interactions in Alzheimer's Disease: a Potential Path to Precision Medicine
- ©Copyright 2016 Matthew Brodsky
- Idalopirdine, a Selective 5-HT6 Receptor Antagonist, Reduces Food Intake and Body Weight in a Model of Excessive Eating